Botanical species · safety record

Lactuca indica

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Lactuca indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lactuca indica L.

5Constituent measurements

1Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lignans	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Sesquiterpene lactones	Leaves	Solvent extraction	< 0.025 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Sesquiterpene lactones	Roots and other underground parts	Solvent extraction	≥ 0.025 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Sesquiterpene lactones	Roots and other underground parts	Solvent extraction	≤ 0.25 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Sesquiterpene lactones	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Leaves	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Kwon, H.J., Jeong, E.K., Jeong, H.J., Kim, S.C., Heo, N.K., No, H.S. Proximate compositions and biological activities of Lactuca indica L. Seonhyang and wild species depending on harvesting time. Journal of the korean society of food science and nutrition, 2015, vol. 44, no. 3, p. 363-369. DOI
Michalska, Klaudia., Stojakowska, Anna., Malarz, Janusz., Dolezalova, Ivana., Lebeda, Ales., Kisiel, Wanda. Systematic implications of sesquiterpene lactones in Lactuca species. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2009, vol. 37, no. 3, p. 174-179. DOI
Hou, CC., Lin, SJ., Cheng, JT., Hsu, FL. Antidiabetic dimeric guianolides and a lignan glycoside from Lactuca indica. JOURNAL OF NATURAL PRODUCTS, 2003, vol. 66, no. 5, p. 625-629. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature